GRI Bio Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $5.71M
Latest Deal Amount

GRI Bio General Information

Description

Developer of therapies created to treat inflammatory diseases. The company's cell-based therapies are developed to treat liver disease and autoimmunity deficiencies by targeting the regulation of NKT cells.

Contact Information

Website
www.gribio.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 2223 Avenida De La Playa
  • Suite 105
  • La Jolla, CA 92037
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GRI Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 07-Nov-2018 $5.71M 00.000 Completed Generating Revenue
2. Angel (individual) Cancelled Generating Revenue
1. Angel (individual) 17-Apr-2015 $4.38M $4.38M Completed Generating Revenue
To view GRI Bio’s complete valuation and funding history, request access »

GRI Bio Executive Team (4)

Name Title Board Seat Contact Info
Sean Edwards JD President & Co-Chief Executive Officer
Vipin Chaturvedi Ph.D Chief Scientific Officer, Board Member and Co-Founder
Marc Hertz Ph.D Co-Founder, Chairman & Chief Executive Officer
Albert Agro Ph.D Senior Vice President of Clinical Development, Board Member and Co-Founder
To view GRI Bio’s complete executive team members history, request access »

GRI Bio Board Members (5)

Name Representing Role Since
Abraham Van Wyk Self Board Member 000 0000
Albert Agro Ph.D Self Senior Vice President of Clinical Development, Board Member and Co-Founder 000 0000
Marc Hertz Ph.D GRI Bio Co-Founder, Chairman & Chief Executive Officer 000 0000
Vipin Chaturvedi Ph.D GRI Bio Chief Scientific Officer, Board Member and Co-Founder 000 0000
You’re viewing 4 of 5 board members. Get the full list »

GRI Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial